阅读说明：本技术 用于产生气态活性成分或气态活性成分混合物的装置 (Device for producing a gaseous active ingredient or a mixture of gaseous active ingredients ) 是由 弗里茨·施密特 于 2019-12-10 设计创作，主要内容包括：本发明涉及一种套件、一种用于产生气态活性成分或气态活性成分混合物的方法以及一种可采用所述方法获得的气态组合物,该套件包括：a)带有出口的袋子,其中,所述出口可封闭和打开；b)固体的和/或液体的活性成分前体；和c)用于从所述活性成分前体中释放气态活性成分或气态活性成分混合物的机构,该方法包括以下步骤：a)提供所述套件；b)提供在袋子中的固体的和/或液体的活性成分前体；c)借助用于释放气态活性成分或气态活性成分混合物的机构,从固体的和/或液体的所述活性成分前体中释放所述气态活性成分或气态活性成分混合物。(The present invention relates to a kit, a method for producing a gaseous active ingredient or a mixture of gaseous active ingredients and a gaseous composition obtainable with said method, the kit comprising: a) a bag with an outlet, wherein the outlet is closable and openable; b) a solid and/or liquid active ingredient precursor; and c) means for releasing a gaseous active ingredient or a mixture of gaseous active ingredients from said active ingredient precursor, the method comprising the steps of: a) providing the kit; b) providing a solid and/or liquid active ingredient precursor in a pouch; c) releasing the gaseous active ingredient or the mixture of gaseous active ingredients from the solid and/or liquid active ingredient precursor by means of a mechanism for releasing the gaseous active ingredient or the mixture of gaseous active ingredients.)

1. A kit, comprising:

a. a bag with an outlet, wherein the outlet is closable and openable;

b. a solid and/or liquid active ingredient precursor; and

c. means for releasing a gaseous active ingredient or a mixture of gaseous active ingredients from the active ingredient precursor.

2. The kit of claim 1, wherein the active ingredient precursor is disposed in the bag.

3. A kit according to claim 1 or 2, wherein the active ingredient precursor comprises cannabis flowers, cannabis leaves, cannabis paste, cannabis oil, at least one cannabinoid, or a mixture thereof.

4. A kit according to any preceding claim, wherein the outlet comprises a mouthpiece.

5. A kit according to any one of claims 1 to 3 wherein the outlet includes means for connecting the outlet to a mouthpiece.

6. Kit according to any one of the preceding claims, wherein the means for releasing the gaseous active ingredient or the mixture of gaseous active ingredients comprises heating means, preferably chemical heating means.

7. A kit according to any one of the preceding claims, wherein the bag comprises a first chamber and a second chamber, wherein,

the first chamber contains a solid and/or liquid active ingredient precursor and is connected with the second chamber;

the outlet is disposed at the second chamber.

8. A method for producing a gaseous active ingredient or a mixture of gaseous active ingredients, comprising the steps of:

a. providing a kit according to any of the preceding claims;

b. providing a solid and/or liquid active ingredient precursor in a pouch;

c. releasing the gaseous active ingredient or the mixture of gaseous active ingredients from the solid and/or liquid active ingredient precursor by means of a mechanism for releasing the gaseous active ingredient or the mixture of gaseous active ingredients.

9. The method of claim 8, wherein said releasing comprises heating a solid and/or liquid precursor of said active ingredient.

10. The method according to claim 9, wherein the solid and/or liquid active ingredient precursor is heated during the heating to a temperature in the range of 170 ℃ to 220 ℃, preferably 185 ℃ to 210 ℃.

11. A gaseous composition obtainable by a process according to any one of claims 8 to 10, wherein,

the active ingredient precursor comprises cannabis flos, cannabis folium, cannabis extract, cannabis oil, at least one cannabinoid, or mixtures thereof; and is

The solid and/or liquid active ingredient precursor is heated during heating to a temperature in the range from 170 ℃ to 220 ℃, preferably from 185 ℃ to 210 ℃.

Technical Field

The present invention relates to a method for producing a gaseous active ingredient or a mixture of gaseous active ingredients, a kit for use in the method and a gaseous composition obtainable by the method.

Background

A large number of different devices are known from the prior art, which attempt to heat substances, herbs or liquids at a specific temperature using hot air, hot plates or glow wires, in order to have the desired active ingredient available for inhalation. Most known devices work according to the "hot plate principle". That is, the plant parts containing the active ingredient are spread over the heated surface, in which case the ingredient is expected to evaporate. The effect of this method is not ideal because the substance in direct contact with the heated surface is heated to a much greater extent than the substance in the layer lying above it, and thus a homogeneous evaporation of the components cannot be achieved.

In another functional principle, parts of the plant are flowed through by air heated to a range of temperatures. The plant parts are then-with the necessary minimum temperature being present-allowed to evaporate their constituents which can then be inhaled after cooling. These devices do not guarantee the safety of the device, particularly when used in the medical field. All the prerequisites for medical equipment are missing, since the equipment cannot be sterilized. However, this is highly desirable if the expected combustion residue on the heating plate ("grill") is taken into account.

Disclosure of Invention

It is therefore an object of the present invention to provide a method for releasing an active ingredient from a corresponding precursor mixture using a medically approved mechanism, which overcomes the disadvantages of the prior art and is particularly suitable for releasing an active ingredient from a corresponding precursor mixture in a gentle manner.

This object is firstly achieved by a kit comprising: a) a bag with an outlet, wherein the outlet is closable and openable; b) a solid and/or liquid active ingredient precursor; and c) means for releasing the gaseous active ingredient or the mixture of gaseous active ingredients from the active ingredient precursor.

The kit according to the invention enables the release of gaseous active ingredients from solid and/or liquid active ingredient precursors in a simple and gentle manner. It can be provided here that the active ingredient is a pharmacologically active ingredient. After release, the gaseous active ingredient or gaseous active ingredient mixture may be inhaled or inhaled for medical purposes. It is well known that inhalation of active ingredients is particularly effective, since the route through the stomach (in the case of oral administration) or the portal circulation (in the case of injection) is thereby eliminated. Furthermore, absorption of the active ingredient is supported by oral mucosal absorption. The kit according to the invention and the method according to the invention (as described further below) enable the patient to take up in the lungs a pharmacologically active ingredient which acts locally limitedly in the lungs or rapidly enters the blood circulation via the alveoli and acts systemically there. In the case of topical treatment, side effects in the remaining tissue can be reduced and lower doses are required, since a greater proportion of the dose reaches the site of action than is the case with oral administration. But even if the active ingredient is to enter the blood circulation to produce a systemic effect, a lower dose is usually required because the first pass effect in the liver is bypassed. Due to the large absorption area of the lungs (about 70-100 square meters) and the thin epithelial lining, the active ingredient enters the body more rapidly and can act earlier than if taken orally.

Another advantage of the kit according to the invention is its flexibility. Depending on the patient and its needs, the active ingredient precursors can be prepared separately and tailored to the patient by the pharmacist and then provided in a kit for administration.

In one embodiment, it can be provided that the active ingredient precursor is arranged in a bag. The amount of active ingredient precursor may be adjusted to the patient such that the amount of gaseous active ingredient released from the active ingredient precursor corresponds approximately to the lung volume of the patient (e.g. +/-10% by volume). In this connection, it can be provided that the amount of gaseous active ingredient released is 10 times, preferably 20 times, particularly preferably 30 times the total volume of the bag. A particularly effective administration of the gaseous active ingredient tailored to the patient can thereby be achieved.

In one embodiment it may be provided that the active ingredient precursor comprises cannabis flowers, cannabis leaves, cannabis paste, cannabis oil, at least one cannabinoid or a mixture thereof.

Cannabis sativa (cannabis) together with Humulus (Humulus) belong to the cannabidae family, but the Humulus plant does not contain cannabinoids. Within the Cannabis genus, there are differences in the botanical and chemical taxonomic categories, specifically the species Cannabis sativa Linnaeus (Cannabis sativa Linnaeus), Cannabis indica (Cannabis indica) LAM and Cannabis sativa (Cannabis ruderalis), or the "collective species" Cannabis sativa (Cannabis sativa L.), which consists of the subspecies Cannabis sativa ssp. In addition, cannabis is divided into medicinal and fibrous cannabis, among which Cannabidiol (CBD) and Δ, the main cannabinoids⁹-tetrahydrocannabinol (Δ)⁹-THC) (INN: dronabinol) were distinguished. The fiber hemp (also known as industrial hemp) is used mainly for industrial fiber production and can have a delta of at most 0.2%⁹THC content (e.g. Germany, etc.), whereas the drug classes may have a.DELTA.of about 5-15%⁹-THC content (hemp leaf, hemp paste). Cannabis sativa l. contains 400 different components, of which over 60 compounds belong to the cannabinoids. The major cannabinoids are as follows:

o Cannabinols (CBG): cannabinol ((E) -CBG-C)₅) Cannabinol monomethyl ether ((E) -CBGM-C)₅A) Cannabinolic acid A ((Z) -CBGA-C)₅A) Cannabidiol ((E))-CBGV-C₃) Cannabidiolic acid A ((E) -CBGA-C)₅A) Cannabidiolic acid A monomethyl ether ((E) -CBGAM-C)₅A) Cannabidiolic acid A ((E) -CBGVA-C)₃ A)；

o cannabinoids (CBC): cannabinoid (CBC-C)₅) Cannabinoid acid A (CBCA-C)₅A) Cannabis pigment (CBCV-C)₃) Cannabichromenic acid A (CBCVA-C)₃ A)；

o Cannabidiol (CBD): cannabidiol (CBD-C)₅) Cannabidiol monomethyl ether (CBDM-C)₅) cannabidiol-C4 (CBD-C)₄) Cannabidiol (CBDV-C)₃) Cannabidiol (CBD-C)₁) Cannabidiolic acid (CBDA-C)₅) Cannabis diacid (CBDVA-C)₃)；

o Cannabidiol (CBND): cannabidiol (CBND-C)₅) Cannabidiol (CBND-C)₃)；

o Tetrahydrocannabinols (THC): delta 9-tetrahydrocannabinol (Delta 9-THC-C)₅) Delta 9-tetrahydrocannabinol-C₄(Δ9-THC-C₄) Delta 9-tetrahydrocannabinol (delta 9-THCV-C)₃) Delta 9-tetrahydrocannabinol (delta 9-THC-C)₄)-C₁) Delta 9-tetrahydrocannabinolic acid (delta 9-THCA-C)₅A) Delta 9-tetrahydrocannabinolic acid B (delta 9-THCA-C)₅B) Delta 9-tetrahydrocannabinolic acid-C₄(Δ9-THCA-C₄A and/or B), Δ 9-tetrahydrocannabinic acid A (Δ 9-THCVA-C)₃A) Delta 9-tetrahydrocannabidiolic acid (delta 9-THCOA-C)₁A and/or B), (-) -Delta 8-trans- (6aR,10aR)) -Delta 8-tetrahydrocannabinol (Delta 8-THC-C)₅) (-) - Δ 8-trans- (6aR,10aR) -tetrahydrocannabinolic acid A (Δ 8-THCA-C)₅A) (ii) a (-) - (6aS,10aR) -Delta 9-tetrahydrocannabinol ((-) -cis-Delta 9-THC-C)₅)；

o Cannabinols (CBN): cannabinol CBN-C₅cannabinol-C₄(CBN-C₄) Cannabinol (CBN-C)₃) Cannabinol C₂(CBN-C₂) Cannabinol (CBN-C)₁) Cannabinolic acid A (CBNA) -C₅A) Cannabinol methyl ether (CBNM-C)₅)

Cannabitriol (CBT): (-) - (9R,10R) -trans-cannabitriol ((-) -trans CBT-C₅) (+) - (9S,10S) -LargeCanatriol ((+) -trans-CBT-C₅) (±) - (9R,10S/9S,10R) -Cannabatriol ((±) -cis-CBT-C₅) (-) - (9R,10R) -trans [ 10-0-ethyl-cannabitriol](-) -trans-CBT-OEt-C₅) (±) - (9R,10R/9S,10S) -cannabitriol-C₃(±) -trans-CBT-C₃) 8, 9-dihydroxy- Δ 6a (10a) tetrahydrocannabinol (8, 9-Di-OH-CBT-C)₅) Cannabidiolic acid A (CBDA-C)₅ 9-OH-CBT-C₅Esters), (-) - (6aR,9S,10S,10aR) -9, 10-dihydroxy-hexahydrocannabis, cannabinol-C₅(-) -6a,7,10 a-trihydroxy- Δ 9-tetrahydrocannabinol ((-) -cannabidiol), 10-oxo- Δ 6a (10a) tetrahydrocannabinol (OTHC);

o-cannabinoids (Cannabielsoin) Class (CBE) (5aS,6S,9R,9aR) -C₅-cannabinoid (CBE-C)₅),(5aS,6S,9R,9aR)-C₃-cannabinoid (CBE-C)₃) (5aS,6S),9R,9aR) -cannabidiolic acid A (CBEA-C)₅A) (5aS,6S,9R,9aR) -cannabidiolic acid B (CBEA-C)₅ B),(5aS,6S,9R,9aR)-C₃Cannabidiolic acid B (CBEA-C)₃B) cannabidiol-C₃(OH-iso-HHCV-C₃) Dehydrocannabinofuran (DCBF-C)₅) Cannabis sativa furan (CBF-C)₅)；

Iso-cannabinoids: (-) - Δ 7-trans- (1R,3R,6R) -isobutrolol, (±) - Δ 7-1,2-cis- (1R,3R,6S/1S,3S,6R) -isobutrolol, (-) - Δ 7-trans- (1R,3R,6R) -isobutrolol;

cannabidiol (Cannabicyclol) group (CBL) (+ -) - (1aS,3aR,8bR,8 cR-cannabidiol (CBL-C)₅) (±) - (1aS,3aR,8bR,8 cR-cannabidiolic acid A (CBLA-C)₅A) (±) - (1aS,3aR,8bR,8 cR-cannabidiol (CBLV-C)₃)；

o Cannabinoids (CBT): cannabinoid (CBT-C)₅)；

o cannabichromene (CBCN): cannabis sativa chromanone (CBCN-C)₅) Cannabinone-C₃(CBCN-C₃) Cannabis sativa chromanone (CBCON-C)₅)。

In addition to the cannabinoids mentioned above, their associated carboxylic acids are present in the drug substance. These carboxylic acids are precursors for biosynthesis.

Cannabis preparations have a variety of therapeutic effects including anti-spasmodic, analgesic, antiemetic, neuroprotective, anti-inflammatory and psychotropic effects (Grotehermen F, Muller-Vall K: The therapeutic potential of cannabis and cannabinoids).

In germany, a cannabis extract containing THC (dronabinol) and CBD (naphthol) in a ratio of 1:1 has been approved as a sublingual spray (Sativex) for the treatment of moderate to severe, refractory spasms of Multiple Sclerosis (MS) since 2011 according to pharmaceutical legislation.

Cannabidiol (CBD, CBD-C)₅) Is the most important non-psychoactive cannabinoid in the cannabis genus, CBD is not a cannabinoid receptor agonist.

FIG. 1: CBD (structural formula)

CBD can be produced synthetically (Michoulam R, Shvo y., hashish.i.the structure of cannabidiol, Tetrahedron 1963,19(12), 2073).

The outlet may be closed and opened. This means that the outlet can be opened, for example by applying a negative pressure (suction) or by mechanical means, to allow the gaseous active ingredient or the mixture of gaseous active ingredients to escape from the bag for application, and can then be closed again in order to store the remaining gaseous active ingredient or the remaining mixture of gaseous active ingredients in the bag.

In one embodiment, it can be provided that the outlet comprises a mouthpiece. Alternatively, it can be provided that the outlet comprises means for connecting the outlet to the mouthpiece. The mouthpiece is here a tubular member through which gas can be conveyed, for example by means of underpressure (suction). In this way, administration of the released gaseous active ingredient is facilitated.

In this connection it can be provided that the mouthpiece is part of the outlet, i.e. the outlet together with the mouthpiece is a one-piece component connected to the bag. It can also be provided that the outlet and the mouthpiece are two different parts which can be connected to each other, for example by screwing the mouthpiece onto the outlet, snapping on, etc. Furthermore, it can be provided that the combination of outlet and mouthpiece comprises further components, such as a rotatable collar, a plug connection, a hinge and further components for connection. In particular, it can be provided that the outlet also comprises a mouthpiece support if the outlet does not integrally comprise a mouthpiece. It can be provided that the mouthpiece and/or the outlet are formed from a plurality of parts, wherein the individual parts forming the mouthpiece and/or the outlet can be connected to one another.

In a further embodiment, it can be provided that the mouthpiece comprises an air inlet. Furthermore, it can be provided that the mouthpiece additionally comprises an intake air adjustment. In this way, the concentration of the ambient air and the amount of gaseous active ingredient from the bag can be regulated in a simple manner.

In one embodiment, it can be provided that the outlet comprises a piercing cannula and/or a piercing membrane. It is thereby possible to ensure particularly effectively that no active ingredient (prior to the application of the gaseous active ingredient or the mixture of gaseous active ingredients) escapes unintentionally.

The means for releasing the gaseous active ingredient or the mixture of gaseous active ingredients from the active ingredient precursor may be arranged outside the bag or inside the bag. It can also be provided that the means for releasing the gaseous active ingredient or the mixture of gaseous active ingredients from the active ingredient precursor are connected to the bag or form part of the bag. In one embodiment, it can be provided that the means for releasing the gaseous active ingredient or the mixture of gaseous active ingredients are arranged in the bag and/or are connected to the bag.

In principle, the mechanisms for releasing the gaseous active ingredient or the gaseous active ingredient mixture from the active ingredient precursor are not limited as long as they allow the release of the relevant pharmacologically active ingredient from the solid and/or liquid active ingredient precursor. The following mechanisms or mechanisms allowing the performance of one or more of the following method steps are suitable:

-extraction of

-distillation

-pressing

Fractionation of

-cleaning

Enrichment of

Fermentation of

Temperature of

-ultrasound

-electromagnetic waves

-bacteria

-fungi

In one embodiment, it can be provided that the means for releasing the gaseous active ingredient or the gaseous active ingredient mixture comprise a heating means, preferably a chemical heating means.

The heating means may for example comprise a heating coil, preferably made of platinum or gold foil. The metal foil functions like a heating wire in a bulb, but does not burn out. The heating coil placed in the bag may be powered by a battery, typically a lithium ion battery.

The chemical heating member is a heating member in which heat is generated by an exothermic reaction of one or more compounds (heat-generating composition; heat-generating reactant) contained in the heating member. For example, it can be provided that, as reactants, acid anhydrides or acid salts and basic anhydrides or basic salts are used, wherein the basic salts can be selected from the group consisting of sodium acetate, sodium benzoate and potassium ascorbate. Inert materials selected from the group consisting of oils, waxes, surfactants may also be included.

If two different compounds which react with one another in an exothermic reaction are contained in the chemical heating component, it can be provided that these compounds are present in different reservoirs before activation, which reservoirs prevent those compounds from accidentally mixing and reacting. By activating the opening means, the reservoir is opened, allowing the two reactants to come into contact and react and release heat. Contact between the two materials results in an exothermic chemical reaction. Alternatively, the first reservoir may also contain a fuel, such as an alcohol, and the second reservoir may contain an oxidant, such as a permanganate compound, so that a heat-generating chemical reaction also occurs when the two materials come into contact. The use of chemical heating means allows the use of the cartridge according to the invention independently of the power supply.

In one embodiment, it can be provided that the bag comprises a film, preferably made of one or more plastics, preferably selected from the group consisting of: polyethylene terephthalate, copolyesters of polyethylene terephthalate with isophthalic acid and diethylene glycol, polyethylene naphthalate, polyethylene furanoate, polylactide, and mixtures thereof. This makes it possible to produce the bag reliably and simply.

In a further embodiment, it can be provided that the bag comprises a first chamber and a second chamber, wherein the first chamber contains a solid and/or liquid precursor of the active ingredient and is connected to the second chamber; the outlet is arranged at the second chamber. It is thereby possible to prevent solid and/or liquid portions of the active ingredient precursor from reaching the outlet in an undesired manner.

The first chamber can here be made of a thermoplastic film, in particular PET, PET copolyester with isophthalic acid and diethylene glycol, PET, PEN, PEF, PLA. The second chamber may be made of a foil or aluminum foil with one, two or even more layers, aluminum foil, foil coated on one or both sides if necessary, etc.

In a further embodiment, it can be provided that the bag further comprises a connector adapted to connect the additional tank to the bag. In which additional tank, for example, oxygen or other gaseous substances can be stored. The fitting enables these additional substances to be introduced into the bag in a simple manner.

In a further embodiment, it can be provided that the permeability of the bag to carbon dioxide is greater than 1.0 x 10^-2ml/(cm²Atm day), preferably more than 2.0 atm 10^-2m)/(cm²Atm day). It can also be provided that the gas permeability of the bag for the gaseous active ingredient or the mixture of gaseous active ingredients is less than 10 x 10^-2ml/(cm²Atm day).

In addition, many other embodiments may contribute to the advantageous design of the invention.

It may be provided that the bag, and in particular the outlet thereof, comprises a child-resistant portion.

It can be provided that the bag is made of fabric, in particular using carbon fibers.

It can be provided that the bag is made of a film.

It can be provided that the bag is made of a material which reacts to changes in temperature with changes in colour.

It may be provided that the kit further comprises a thermometer, which indicates the temperature inside the bag.

Provision can be made for the heating element to be produced using mercury vapor.

Provision can be made for heat to be generated in the heating element, in particular in the chemical heating element, by catalytic action.

It may be provided that the solid active ingredient precursor comprises ground cannabis flowers, preferably in a flour design. It can be provided that a solid and/or liquid active ingredient precursor is arranged at least partially in the form of a coating on the inside of the bag. In particular, it can be provided that the inside of the bag is coated with ground hemp flowers, in particular in a flour-like design. A particularly high specific surface area of the active ingredient precursor is thereby achieved, which in turn facilitates the release of the gas.

It can be provided that the gaseous active ingredient or the mixture of gaseous active ingredients is a medicament and/or a vaccine. Thereby, for example, a natural process can be realized.

It may be provided that the kit comprises a propellant composition in the form of a heating unit, a nutrient solution and microorganisms or herbs and flowers.

In a further embodiment it can be provided that the first chamber is made of an unobstructed thermoplastic film, in which first chamber herbal, floral and plant ingredients or nutrient solutions and microorganisms are accommodated, wherein the microorganisms are capable of releasing the active ingredient by fermentation, and that a second container is arranged at the outlet and is used for containing and mixing the composition to be delivered, and/or that a plurality of second containers, which may for example have the shape of spheres, are provided nested one inside the other.

It may be provided that the bag is airtight.

It can be provided that a solid and/or liquid active ingredient precursor is placed in the bag together with the functional component (wherein the functional component can comprise, but is not necessarily limited to, a mechanism for releasing the gaseous active ingredient or the gaseous active ingredient mixture) and that the functional component can be controlled from the outside for releasing the gaseous active ingredient or releasing the gaseous active ingredient mixture.

It can be provided that the inside of the bag is provided with a coating which is suitable for binding gaseous substances which are not gaseous active ingredients or which are not contained in the gaseous active ingredient mixture.

The object is also achieved by a method for producing a gaseous active ingredient or a mixture of gaseous active ingredients, comprising the steps of: a) providing a kit according to any of the preceding claims; b) providing a solid and/or liquid active ingredient precursor in a pouch; c) the gaseous active ingredient or the mixture of gaseous active ingredients is released from the solid and/or liquid active ingredient precursor by means of a mechanism for releasing the gaseous active ingredient or the mixture of gaseous active ingredients.

It can be provided here that the release comprises heating a solid and/or liquid precursor of the active ingredient.

In this connection, it can be provided that the solid and/or liquid active ingredient precursor is heated during the heating to a temperature in the range from 170 ℃ to 220 ℃, preferably from 180 ℃ to 210 ℃, particularly preferably from 185 ℃ to 210 ℃.

Those who ingest cannabis for pharmaceutical purposes wish to extract as many cannabinoids (in particular THC and CBD) as possible from the cannabis plant. These cannabinoids are not present in their pure form in cannabis plants in an efficient way, but as so-called carboxylic acids (THCA and CBDA). These carboxylic acids need to be converted to THC and CBD. This is achieved by so-called decarboxylation. In the process, one molecule of carbon dioxide is separated from the carboxylic acids THCA and CBDA, respectively. The desired compounds THC and CBD remained.

Decarboxylation may be initiated thermally. Thus, when the present invention is employed to vaporize hemp, electronic regulation is used to ensure that the correct vaporization temperature is set. This should preferably be between 180 and 210 degrees celsius.

The following process steps may be employed: the hemp is first heated to just 180 deg.c with electromagnetic wave and the temperature is controlled to 1 deg.c with the sensor. The temperature can be raised to 210 ℃ in order to dissolve as much cannabinoid as possible. Of course, hemp oil or extract may also be used.

Another advantage of the method according to the invention is: the residence remains odorless. Any person who consumes cannabis in their residence must expect to smell the smoke within the next few days. There is no such risk of evaporation.

The heating process is performed in the absence of oxygen, thereby preventing the flowers from burning.

Cannabis sativa can be comminuted prior to use. Grinding balls which can be moved by means of magnets are suitable for this. The enhancement effect can be achieved by inductively heating the metal balls.

According to the present invention, cannabis may be combined with other medicinal plants, depending on the therapy. This is easily achieved with the present method, since the bag can be combined with different chambers several times. In this case, the effect of cannabis can be supported due to the retinue effect.

It can be provided that the kit comprises further functional components. The following features are exemplarily mentioned herein.

-material for binding liquid

-a filter material

-heating means

-mechanical grinding machine

All materials which produce chemical or mechanical reactions

-electrostatically charged components

-centrifuge

-a catalyst

-ultraviolet filter

Finally, the object is achieved by a gaseous composition obtainable with the method according to the invention, wherein the active ingredient precursor comprises cannabis flowers, cannabis leaves, cannabis paste, cannabis oil, at least one cannabinoid or a mixture thereof; and during the heating the solid and/or liquid active ingredient precursor is heated to a temperature in the range from 170 ℃ to 220 ℃, preferably from 180 ℃ to 210 ℃, particularly preferably from 185 ℃ to 210 ℃.

Drawings

The invention is described below with the aid of specific embodiments and with reference to the accompanying drawings. It should be understood herein that the reference to specific embodiments is only for the purpose of illustrating the invention. The features of the specific embodiments do not necessarily limit the invention, but can contribute to an advantageous implementation of the invention, in particular in combination with the embodiments described above.

FIG. 1: a schematic view of a kit according to an embodiment of the invention.

In fig. 1, the reference numerals have the following meanings:

1 mouthpiece

2 air inlet

3 air intake regulating part

4 a collar rotatable

5 mouthpiece support

6 additional tank

7 plug connection

8 puncture cannula

9 connecting part

10 puncture membrane

11 hinge

12 outlet

13 Fine mesh basket for flowers or other biological materials

14 chemical heating component

15 heating element

16 liquid active ingredient

17 active ingredient incorporated in bag

18 external energy generator

19 bending the part to initiate a chemical reaction

20 set

21 bag cover

23 Joint for external filling

24 heating element

25 for bent metal pieces, initiating chemical reactions

26 noxious substance aspirator with active carbon filter

27 biological material, e.g. hemp flower

28 Filter

29 liquid active ingredient

Detailed Description

In the embodiment shown in fig. 1, a number of features and components are shown as well, which may contribute to an advantageous implementation of the invention. Those skilled in the art will appreciate that all of the features (components, etc.) shown in fig. 1 do not necessarily have to be present at the same time in order to implement an apparatus according to the present invention.

A kit 20 according to the present invention is shown in fig. 1. The kit comprises a bag 21 having an outlet 12 and various means 14, 15, 18, 19, 24, 25 for releasing a gaseous active ingredient or a mixture of gaseous active ingredients from an active ingredient precursor. The pouch 21 contains a solid active ingredient precursor 27 and liquid active ingredient precursors 16, 29. If the solid active ingredient precursor 27 is a finely divided material, for example a powdered material, it may be present in the fine mesh basket 13. Another solid active ingredient precursor is incorporated into a portion of the pouch 17. By mechanical action on this part of the bag 17, the active ingredient precursor contained therein can be released.

The outlet 12 shown in fig. 1 comprises a puncturing membrane 10 and a hinge 11, the hinge 11 connecting the puncturing membrane 10 with the outlet 12 in a suitable manner so that the puncturing membrane is movably arranged. The outlet 12 is designed to be connectable with the mouthpiece 1 and the other parts, i.e. the collar 4, the mouthpiece holder 5 and the plug connection 7. Mouthpiece 1 includes air inlet 2 and filter 28. An air intake adjusting portion 3 is disposed between the mouthpiece 1 and the outlet 12 by means of the collar 4. Together with the plug connection 7, a connection part 9 and a piercing cannula 8 are arranged between the outlet 12 and the mouthpiece holder 5.

Various mechanisms for releasing a gaseous active ingredient or a mixture of gaseous active ingredients from an active ingredient precursor are shown in fig. 1. For example, an external energy generator 18 is shown, which may be a heater disposed outside the bag. Also shown are chemical heating component 14, additional heating component 15, bending component 19 that can initiate an exothermic chemical reaction, another heating component 24, and metal tab 25 that can be bent to initiate an exothermic chemical reaction.

Furthermore, the bag 21 comprises a noxious substance aspirator 26 provided with an activated carbon filter. Finally, the bag has a fitting 23 which allows the bag 21 to be filled with material from the additional tank 6.

The features disclosed in the foregoing description and in the following claims may, both separately and in any combination thereof, form the subject matter of aspects of the disclosure that are in different forms of realizing in the independent claims.